GeneXpert for TB diagnosis: Planned and purposeful implementation

Global Health Science and Practice

Volumn 1, Issue 1, 2013, Pages 18-23

  Piatek, Amy S ^a   Van Cleeff, Maarten ^b   Alexander, Heather ^c   Coggin, William L ^d   Rehr, Manuela ^b   Van Kampen, Sanne ^b   Shinnick, Thomas M ^e   Mukadi, Yadiul ^a  

^a UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d U S DEPARTMENT OF STATE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899642344     PISSN: None     EISSN: 2169575X     Source Type: Journal    
DOI: 10.9745/GHSP-D-12-00004     Document Type: Note

References (10)

1. World Health Organization (WHO). Global tuberculosis control report 2012. Geneva: WHO; 2012. Available from: http:// www.who.int/tb/publications/global-report/en/
2. Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther. 2007;5(3):327-331. CrossRef. Medline
3. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;23:1644-1650. Medline
4. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229-237. CrossRef. Medline
5. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005-1015. CrossRef. Medline
6. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis andmultidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495-1505. CrossRef. Medline
7. World Health Organization (WHO). Rapid implementation of the Xpert MTB/RIF diagnostic test . Geneva: WHO; 2011. Available from: http://whqlibdoc.who.int/publications/2011/ 9789241501569-eng.pdf
8. FIND: Foundation for Innovative New Diagnostics [Internet]. Geneva: FIND. Negotiated prices for XpertH MTB/RIF and FIND country list; 2012 August [cited 2012 Dec 14]. Available from http://www.finddiagnostics.org/about/what-we-do/ successes/find-negotiated-prices/xpert-mtb-rif.html
9. World Health Organization (WHO). Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: WHO; 2010. Available from: http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf
10. UNITAID. Tuberculosis: diagnostic technology landscape .Geneva: UNITAID; 2012. Available from: http://www.unitaid.eu/images/ marketdynamics/publications/UNITAID-Tuberculosis-Landscape- 2012.pdf